| 21 CFR 11, 50, 54, 56, 312, 314, ICH E2A, E6(R3) - Good Clinical Practice Handbook |
| Clinical Master Reference Guide |
| Medical Device Clinical with EU Directive |
| ICH M3(R2) - Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals |
| ICH S6 - Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals |
| 21 CFR 50, 54, 56 - GCP Drug Approval Handbook |
| 21 CFR 54 - Financial Disclosure by Clinical Investigators |
| ICH E2A - Clinical Safety Data Management: Definitions and Standards for Expedited Reporting |
| ICH E8 - General Considerations for Clinical Studies |
| ICH Q2(R2) and ICH Q14 Analytical Validation |
| ICH E6(R3) - Good Clinical Practice |
| 21 CFR 320 - Bioavailability and Bioequivalence Requirements |
| GCLP Good Clinical Laboratory Handbook - 4.5x7.5 |
| ICH M10 Bioanalytical Method Validation |
| GLP Analytical Stability Handbook - 4.5x7.5 |
| Parts 11, 606 and 1271 - Blood Cell & Tissue GMPs |
| 21 CFR Part 11, 58 GLP and OECD Series 1 GLP |
| Parts 11, 606 and 1271 - Blood, Cell & Tissue with Annex 14 |
| In Vitro Diagnostics Master Handbook |
| VICH GL9 Animal GCP |
| Title 21 CFR Parts 1 - End Nine Volume Set |
|
- Guaranteed Lowest Price
- Quantity Discounts Available
- Always Current, Up-To-Date
- Company Logos Available
- Special Customizations
- Pocket-sized 3.75" x 6.25"
- Prep for FDA & Client Audits
- Employee Training & Reference
- Promotional "giveaways"
- Tradeshows and meetings
-
|
